Literature DB >> 4057402

Transseptal crossed vasovasostomy.

E F Lizza, J L Marmar, S S Schmidt, J A Lanasa, I D Sharlip, A J Thomas, A M Belker, H M Nagler.   

Abstract

We examined 11 patients with acquired obstructive azoospermia resulting from irreparable obstruction of 1 vas deferens and severe damage to the contralateral testis. All of the patients underwent transseptal crossed vasovasostomy with no morbidity. Of 8 patients evaluated with postoperative semen analyses 4 (50 per cent) demonstrated total sperm counts of 29 to 205 million and 2 pregnancies (25 per cent) have been reported, with followup ranging from 5 months to 2 years. The etiologies of the vasal obstruction included previous inguinal surgery in 7 patients, vasectomy in 1, ejaculatory duct obstruction in 1, ectopic ureter in 1 and vasal agenesis in 1. Factors leading to loss of the contralateral testis were torsion in 5 patients, mumps orchitis in 2, varicocele in 1, pediatric inguinal herniorrhaphy in 1, epididymal blow out in 1 and unknown in 1. A representative case involving a unilateral ectopic ureter emptying into the seminal vesicle and subsequent contralateral testicular torsion is presented. The results indicate that a transseptal crossed vasovasostomy should be done in patients satisfying the criteria presented.

Entities:  

Mesh:

Year:  1985        PMID: 4057402     DOI: 10.1016/s0022-5347(17)47657-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

Review 1.  The evolution of vasectomy reversal.

Authors:  Ryan M Dickey; Alexander W Pastuszak; Tariq S Hakky; Aravind Chandrashekar; Ranjith Ramasamy; Larry I Lipshultz
Journal:  Curr Urol Rep       Date:  2015-06       Impact factor: 3.092

2.  The history of microsurgery in urology.

Authors:  Alexander W Pastuszak; Evan P Wenker; Larry I Lipshultz
Journal:  Urology       Date:  2015-05       Impact factor: 2.649

3.  Crossover transseptal vasovasostomy: alternative for very selected cases of iatrogenic injury to vas deferens.

Authors:  Fernando Korkes; Oseas Castro Neves
Journal:  Int Braz J Urol       Date:  2019 Mar-Apr       Impact factor: 1.541

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.